Catosal 100 mg/ml + 0.05 mg/ml solution for injection for cattle, horses and dogs
Catosal 100 mg/ml + 0.05 mg/ml solution for injection for cattle, horses and dogs
Authorised
- Butafosfan
- Cyanocobalamin
Product identification
Medicine name:
Catosal 100 mg/ml + 0,05 mg/ml injekčný roztok pre hovädzí dobytok, kone a psy
Catosal 100 mg/ml + 0.05 mg/ml solution for injection for cattle, horses and dogs
Active substance:
- Butafosfan
- Cyanocobalamin
Target species:
-
Cattle
-
Dog
-
Horse
Route of administration:
-
Intravenous use
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Butafosfan100.00/milligram(s)1.00millilitre(s)
-
Cyanocobalamin0.05/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intravenous use
-
Cattle
-
Meat and offal0day
-
Milk0hour
-
-
Horse
-
Meat and offal0day
-
Milk0hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA12CX99
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Slovakia
Package description:
- (ID2) 250 millilitre(s): Box (board) with 1 Vial (Glass type I) with 250 millilitre(s), closed with Stopfen (chlorobutyl rubber) and Cap`` (aluminium)
- (ID1) 100 millilitre(s): Box (board) with 1 Vial (Glass type II) with 100 millilitre(s), closed with Stopfen (chlorobutyl rubber) and Cap`` (aluminium)
- (ID3) 50 millilitre(s): Box (board) with 1 Vial (Glass type II) with 50 millilitre(s), closed with Stopfen (chlorobutyl rubber) and Cap`` (aluminium)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
- 96/100/MR/94-S
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 4/12/2025
Slovak (PDF)
Published on: 3/01/2025